Fuse Medical, Inc. (FZMD)
Oxford Ledge is still expanding full research coverage of FZMD. A delayed quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
The company conducts payroll, distribution, and manufacturing transactions with multiple entities controlled by its executives.
Source: 10-K (2022-12-31) · AI-generated analysis. Not investment advice. May contain errors.
SEC filings
- 8-K Results of operations / financial condition; Financial statements and exhibits 2023-09-27
- 8-K Results of operations / financial condition; Financial statements and exhibits 2023-08-15
- 10-Q Quarterly financial report (unaudited) 2023-08-14
- 8-K Shareholder vote results 2023-06-26
- 10-Q Quarterly financial report (unaudited) 2023-05-15
Source: SEC EDGAR.
Annual results
5 years of annual figures for FZMD, as filed with the SEC. Figures are as reported and are not restated or adjusted.
| Fiscal year | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| 2022 | $18.6M | $3.1M | $0.04 |
| 2021 | $20.4M | -$1.6M | -$0.02 |
| 2020 | $21.4M | -$1.4M | -$0.02 |
| 2019 | $22.9M | -$3.3M | -$0.05 |
| 2018 | $26.3M | $4.0M | $0.05 |
Source: SEC EDGAR (XBRL company facts). Full statements and ratios in the terminal.
Insider activity
5 recent insider (SEC Form 4) filings on record for FZMD. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open FZMD in the Oxford Ledge terminal — delayed quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.